Today's Date: April 12, 2021
Major League Baseball and SiriusXM Expand Agreement; Games Now Available to SiriusXM's Streaming-Only Subscribers   •   The Children's Heart Foundation's Board of Directors Names Gail Roddie-Hamlin as President and CEO   •   Introducing Vencapital's 5th Class of Minority & Female VC Fellows   •   Statement by Minister Chagger on Ramadan   •   Greenberg Traurig's Natasha Wilson to Speak at Driving Diversity in Law & Leadership Virtual Summit   •   Khoros Appoints April Downing as Chief Financial Officer and Sejal Amin as Chief Technology Officer   •   California State Parks and Hipcamp Announce First of Its Kind Open Data Integration   •   United States Mint Announces First Two Honorees in American Women Quarters Program   •   One Year Into the Pandemic, Groupon Study Shows People Are Ready for JODO (Joy of Doing the Ordinary)   •   CarMax and Dunkin’ are “Doin’ Donuts” for New 24-Hour Test Drive Experience   •   University of Phoenix Hosting Educational Equity Webinar “Healing Racism Beyond the Dialogue: What is Racism?”   •   Meet Mini Bloom, A Clean Baby Care Brand Rooted In Nature And Backed By Science   •   Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year   •   Ancestry® Launches New Impact Program to Foster More Connected, Resilient Communities   •   HEINZ Partners With The LEE Initiative to Help Preserve Black-Owned Restaurants’ Cultural Legacy   •   Statement by the Prime Minister on Ramadan   •   Expensify Releases First Season of New Podcast: Live Rich, Have Fun, Save the World   •   Reprise Commerce Lands DeMert Brands as Its First Direct US Client   •   Corporate Reputations Improve During a Year of Crises according to The RepTrak Company   •   CPSC and Maxtrade Warn Consumers to Stop Using Maxtrade Coolster Youth ATVs Due to Crash Hazard and Violation of Mandatory Safet
Bookmark and Share

Deep Immune Profiling Shows Significant Immune Activation in Children with MIS-C

Deep Immune Profiling Shows Significant Immune Activation in Children with MIS-C

-- CHOP/Penn study shows T cell activation in children with MIS-C more similar to adults with severe COVID-19 --

PR Newswire

PHILADELPHIA, March 2, 2021 /PRNewswire/ -- Taking the first deep dive into how the immune system is behaving in patients with multisystem inflammatory syndrome in children (MIS-C), researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have found that children with this condition have highly activated immune systems that, in many ways, are more similar to those of adults with severe COVID-19. The results, published today in Science Immunology, show that better understanding the immune activation in patients with MIS-C could not only help better treat those patients but also improve treatment for adults with severe COVID-19.

"This study shows that children with MIS-C are tremendously immune activated, particularly when it comes to CD8 T cells, but that this activation subsides once patients begin to improve clinically," said Laura Vella, MD, PhD, attending physician in the Division of Infectious Diseases at CHOP and first author of the study. "Our findings provide a broad immunologic foundation for understanding pathogenesis and recovery in this novel SARS-CoV-2-associated inflammatory syndrome, with potential implications for adult disease."

Pediatricians first recognized MIS-C in April 2020, when pediatric patients began presenting with symptoms involving hyperinflammation, including fever, gastrointestinal distress and cardiogenic shock. The syndrome, thought to be a post-infectious complication of SARS-CoV-2 infection, has similarities in clinical presentation to Kawasaki disease, especially the vascular involvement, but it differs from Kawasaki disease in key ways, including unique clinical, inflammatory, and autoantibody signatures. The syndrome also lacks the respiratory complications typical of adult and pediatric COVID-19. However, until this point, the immunologic features driving MIS-C remained poorly understood.

To better understand the immunology behind MIS-C, the researchers collected blood samples from patients admitted to CHOP with COVID-19 or MIS-C between April and June of 2020. They analyzed more than 200 immune parameters, including serologic and plasma cytokine data, and compared these data with samples from adult COVID-19 patients, recovered adult COVID-19 subjects, and healthy adults.

The researchers found that children with MIS-C had highly elevated T cells, particularly CD8 T cells and a highly activated vascular patrolling CD8 T cell subset. These vascular patrolling CD8 T cells have a proposed role in the control of persisting or reactivating viral infection and have also been implicated in cardiovascular disease, which could have relevance to the vascular symptoms observed in these patients. The researchers found patients with MIS-C, who all had high vascular patrolling CD8 T cells, also required vasoactive support, had elevated D-dimer, and had decreased platelets. The elevation of CD8 T cells far exceeded what the researchers observed in pediatric patients with acute COVID-19 and most adults with COVID-19, but the level of CD8 T cells dropped in MIS-C patients in conjunction with clinical improvement.

The study also highlighted a skewed B cell response in patients with MIS-C compared to acute pediatric COVID-19 and resolved adult disease. Patients with MIS-C are almost universally seropositive for SARS-CoV-2, meaning enough time had passed since infection for an antiviral antibody to develop and be detected. Pediatric and adult patients with acute COVID-19 were not seropositive, consistent with the belief that that MIS-C is a delayed event following SARS-CoV-2 infection. Yet despite MIS-C being a delayed event, the researchers found that MIS-C patients had elevated plasmablasts, or immature plasma B cells, whereas plasmablasts in adults who recover from COVID-19 return to baseline two to three weeks after symptoms resolve, although a subset of hospitalized adult patients with COVID-19 did have a sustained elevation of plasmablasts.

The researchers proposed three possible drivers of the immune pathogenesis in MIS-C: (1) continued activation of adaptive immune responses, driven by persisting SARS-CoV-2 antigen; (2) an additional trigger, such as the virus localizing to a new tissue type or a secondary infection, occurring two to three weeks after the initial infection with SARS-CoV-2; or (3) an autoimmune response. More research is needed to investigated these potential scenarios.

"SARS-CoV2 infection can lead to a broad spectrum of clinical and immunological outcomes," said E. John Wherry, PhD, Director of the Institute for Immunology and senior author of the study. "The use of an 'Immune Health' profiling approach for pediatric COVID-19 patients not only identified distinct features of the pediatric MIS-C presentation of disease, but the insights gained by studying MIS-C patients may reveal new therapeutic opportunities for pediatric and adult COVID-19 patients."

The research was supported by the National Institutes of Health, as well as the University of Pennsylvania Institute for Immunology Glick COVID-19 research award, the Allen Institute for Immunology, a Cancer Research Institute-Mark Foundation Fellowship, the Leukemia and Lymphoma Society, Alex's Lemonade Stand Foundation for Childhood Cancer, and the CHOP Frontiers Program Immune Dysregulation Team.

Vella et al. "Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19," Science Immunology, online March 2, 2021, DOI: 10.1126/sciimmunol.abf7570

About Children's Hospital of Philadelphia: Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. In addition, its unique family-centered care and public service programs have brought the 595-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu

Contact: Dana Bate

Children's Hospital of Philadelphia

(267) 426-6055

bated@chop.edu

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/deep-immune-profiling-shows-significant-immune-activation-in-children-with-mis-c-301238952.html

SOURCE Children's Hospital of Philadelphia



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News